Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis

[1]  M. Guttadauria,et al.  Methotrexate in Rheumatoid Arthritis: Impact on Quality of Life Assessed by Traditional Standard-Item and Individualized Patient Preference Health Status Questionnaires , 1990 .

[2]  P. Tugwell,et al.  Methotrexate in rheumatoid arthritis. Feedback on American College of Physicians guidelines. , 1989, Annals of internal medicine.

[3]  P. Tugwell,et al.  Meta-analysis of injectable gold in rheumatoid arthritis. , 1989, The Journal of rheumatology.

[4]  S. Wahl,et al.  Cyclosporin A in severe, treatment-refractory rheumatoid arthritis. A randomized study. , 1988, Annals of internal medicine.

[5]  E. Thorsby,et al.  HLA-DR mismatch and histologically evaluated rejection episodes in cardiac transplants can be correlated. , 1988, Transplantation proceedings.

[6]  P. Tugwell,et al.  An experiment in reducing interobserver variability of the examination for joint tenderness. , 1988, The Journal of rheumatology.

[7]  M. Dougados,et al.  Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients. , 1988, Annals of the rheumatic diseases.

[8]  N. Madias,et al.  Serum creatinine and renal function. , 1988, Annual review of medicine.

[9]  P. Tugwell,et al.  Low dose cyclosporine in rheumatoid arthritis: a pilot study. , 1987, The Journal of rheumatology.

[10]  P. Tugwell,et al.  Methotrexate in Rheumatoid Arthritis: Indications, Contraindications, Efficacy, and Safety , 1987 .

[11]  T. Pincus,et al.  Questionnaire, walking time and button test measures of functional capacity as predictive markers for mortality in rheumatoid arthritis. , 1987, The Journal of rheumatology.

[12]  M. Weinblatt,et al.  Cyclosporin A treatment of refractory rheumatoid arthritis. , 1987, Arthritis and rheumatism.

[13]  O. Førre,et al.  An open, controlled, randomized comparison of cyclosporine and azathioprine in the treatment of rheumatoid arthritis: a preliminary report. , 1987, Arthritis and rheumatism.

[14]  R. Neary.  Time to scrap creatinine clearance? , 1986 .

[15]  R. Gabriel.  Time to scrap creatinine clearance? , 1986, British medical journal.

[16]  A. Cats,et al.  Cyclosporin treatment for rheumatoid arthritis: a placebo controlled, double blind, multicentre study. , 1986, Annals of the rheumatic diseases.

[17]  N. Tiliakos.  Low dose cytotoxic drug combination therapy in intractable rheumatoid arthritis two years later , 1986 .

[18]  J. Fries,et al.  Survival, prognosis, and causes of death in rheumatoid arthritis. , 1986, Arthritis and rheumatism.

[19]  O. Førre,et al.  Side effects of cyclosporin A treatment in patients with rheumatoid arthritis. , 1986, Kidney international.

[20]  R. Nussenblatt,et al.  Side effects of systemic cyclosporine in patients not undergoing transplantation. , 1984, The American journal of medicine.

[21]  C. Ponticelli,et al.  A Randomized Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous Nephropathy , 1984 .

[22]  M. Homberger,et al.  A radioimmunoassay to measure cyclosporin A in plasma and serum samples. , 1981, Journal of immunoassay.

[23]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .

[24]  I. Jaffe.  The technique of penicillamine administration in rheumatoid arthritis. , 1975, Arthritis and rheumatism.

[25]  E. Huskisson.  Measurement of pain. , 1974, Lancet.